Kite Pharma, Inc. Cash and securities
- Total cash · latest quarter (USD): Value $781.11M; Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2017-06-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2017-06-30..
Cash and securities
Overview →Financial period ending 2017-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | $781.11M | Cash and cash equivalents plus current marketable securities. Period ending 2017-06-30. $147.84M + $633.27M ≈ $781.11M |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2017-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 147.84M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 633.27M USD | Marketable Securities, Current |
| Cash and current securities | 781.11M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2017-06-30 | $781.11M | (m) | $147.84M | $633.27M | (m) |
| 2017-03-31 | $804.03M | (m) | $565.15M | $238.88M | (m) |
| 2016-12-31 | $414.42M | (m) | $114.56M | $299.86M | (m) |
| 2016-09-30 | $477.12M | (m) | $128.75M | $348.37M | (m) |
| 2016-06-30 | (m) | (m) | (m) | $360.97M | (m) |
| 2016-03-31 | (m) | (m) | (m) | $377.82M | (m) |
| 2015-12-31 | (m) | (m) | (m) | $221.88M | (m) |
| 2015-09-30 | (m) | (m) | (m) | $195.60M | (m) |
| 2015-06-30 | (m) | (m) | (m) | $129.65M | (m) |
| 2015-03-31 | (m) | (m) | (m) | $144.61M | (m) |
| 2014-12-31 | (m) | (m) | (m) | $157.74M | (m) |
| 2014-09-30 | (m) | (m) | (m) | $116.37M | (m) |
| 2014-06-30 | (m) | (m) | $203.40M | (m) | (m) |
| 2014-03-31 | (m) | (m) | $18.63M | (m) | (m) |
| 2013-12-31 | (m) | (m) | $22.36M | (m) | (m) |
| 2013-09-30 | (m) | (m) | $24.13M | (m) | (m) |
| 2013-06-30 | (m) | (m) | $25.93M | (m) | (m) |
| 2012-12-31 | (m) | (m) | $8.65M | (m) | (m) |
| 2011-12-31 | (m) | (m) | $11.18M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.